14th Global Commercial and SFE Summit, G

14th Global Commercial and SFE Summit

16-17 October 2024

You should not miss this annual opportunity if you are - Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from:

REQUEST FULL AGENDA

Executive Management Boards
Strategy and Business Development
Commercial Excellence & Effectiveness, Customer Experience/ Excellence
Marketing and Business Units
Sales Force
Sales and Marketing Operations
Market Access
Sales
Group Product Strategy/ Management
PMO
Business Planning/ Intelligence/ Support
Business Analysts
CRM
KAM

For group discounts and complete details contact us.

WHO SHOULD ATTEND

CONFERENCE BENEFITS

Get engaged with the professionals from leading industries
20+ Keynote Sessions
5+ Workshop sessions
Round Table Discussions – Brain storming
Panel Discussions – Interact Directly with the Panellists to raise your challenges
More than 10 Case Studies presenting by the top experts from across the industry
13+ hours Networking Opportunity
Benchmarking Opportunities
One-to-one interactions
Tea/Coffee Breaks, Social Events and Cocktail Reception
.…and much more!

REQUEST FULL AGENDA

Opportunity to meet top expert and decision makers from Pharma, Biotech, Medical Devices, Clinical Sites and CROs industry under one Roof

OVERVIEW

Change your approach to your sales force, customers and find your future commercial model

14th Annual Global Commercial and Sales Force Effectiveness Summit on 16th - 17th October 2024 by KP-Morgan brings the professional views of Commercial, Customers, and sales force experts together under one roof.

To exchange their knowledge, experience, cutting-edge ideas and reveal the challenges for the implementing the best commercial models, Digital Commerce, achieving customers excellence, customer centricity & excellence, establishing a value healthcare system, improving the sale operations, future selling model evolution challenging and competitive market.

A new wave for commercial effectiveness, multichannel, AI and digital initiative, integration CRM into territory management, integration of
Market Access into commercial activities, measuring the performance techniques alongside with people engagement and e-Cababilities innovation within commercial and sales force environment.

INTERESTED IN EVENT PARTNERSHIP?

KP Morgan specializes in clinical trials, SFE, commercial excellence and Healthcare innovation events, hosting events in various locations such as Canada, USA, Europe and Dubai.

KP-Morgan Conferences have provided platforms for debate across many industry sectors including: Telecommunication, banking & financial services, retail and FMCG, investments, pharmaceuticals, IT, chemical & petro chemical.

Many argue that the innovation process cannot be managed because innovation is supposed to be about creativity and cannot be predicted. We believe in KP-Morgan that Innovation is not only about being creative and inventive; innovation is a collaborative process where ideas are taken and managed through to value-adding market introduction.

The consistent high quality of our events has given rise to a reputation for excellence, ensuring that KP-Morgan conferences provide the most fertile ground for participants to gain up-to-the-minute market intelligence and invaluable opportunities to network and generate new business.

About KP-Morgan Group

AGENDA: TOPICS AT GLANCE

Keynote Presentation, Interactive Discussions, Case Studies, Brain Storming and Round Table Discussions

OPEX, Study Feasibility and Site Selection, Activation, Management

Tools to effectively plan, manage and track your clinical study portfolio
How to simplify CT management workflows
Data capture through BOYD & virtual
Changing roles of Clinical Project Managers
Study Feasibility: Right at first
How to use patient insights to improve clinical trial design and operations
Health Equity and diversity in Clinical Trials
Is there a need of digital enabled CRAs
What technologies shall sites use to meet the hybrid or virtual approach
DCTs – Why a way to the future
Remote Monitoring: Maximising the value and what does future hold
Biomarkers, trial, endpoints and remote monitoring tools
Risk Based Approach: Why change to RBM?
Evolution of data science in data management
Importance of virtual & remote trials
Cross Table talk between Sponsor & Sites

Site Inspection Readiness
How to have organized study programs
Site Selection, Activation & Management
Study Startup and resource allocations
Research-naive sites & Site staff training & motivation
Minimizing the unpredictable environment on budget perspective
Minimizing the confusions between sponsors & physicians/sites/labs
Digitalisation of site selection & activation
KPIs – Speed, Cheap & Quantity
Challenges in Clinical Development – Adapting into the new landscape
Growing SOPs complexity
Engagement of Investigators in Business Models or Clinical Trial protocols
Patient Involvement in Clinical Trial Design

PATIENT EMPOWERMENT: AS PARTER

Patient journey mapping
How to retain patients in long run trials
Engaging Patients in Recruitment Strategies in Clinical Trial
Patient awareness program
Holistic approach to patient recruitment
Patient journey mapping
Case Study: Oncology Trials, Rare Diseases Trials, Diabetes Trials

Patient Centric Approaches
What role sites can play in patient recruitment
Patient recruitment online tools
Demonstrating Patient Insight from an early stage of drug development
Advancing use of patient centric platform trials
Patient Recruitment in Emerging countries and Challenges for Global Trials
Data driven patient recruitment

CLINICAL TECHNOLOGIES & TRENDS

eClinical Outcome Assessments/ePRO
(electronic Patient-Reported Outcome) Methods
A hybrid model for enablement of decentralized clinical trials and remote centralized monitoring (eSource)